These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10908844)

  • 61. [Modern chemotherapy of invasive bladder cancer].
    Géczi L
    Magy Onkol; 2007; 51(2):133-8. PubMed ID: 17660869
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Progress in the management of metastatic bladder cancer.
    Parimoo D; Raghavan D
    Cancer Control; 2000; 7(4):347-56. PubMed ID: 10895129
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gemcitabine in bladder cancer.
    Sternberg CN
    Semin Oncol; 2000 Feb; 27(1 Suppl 2):31-9. PubMed ID: 10697034
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of gemcitabine/paclitaxel chemotherapy on the survival of patients with metastatic urothelial cancers.
    Matsui Y; Nishiyama H; Yoshimura K; Xing ND; Sumiyoshi T; Saito R; Inoue T; Kamba T; Ogawa O
    Int J Clin Oncol; 2013 Apr; 18(2):321-8. PubMed ID: 22410820
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional cell carcinoma of the urothelial tract.
    Uhm JE; Lim HY; Kim WS; Choi HY; Lee HM; Park BB; Park K; Kang WK
    Neoplasia; 2007 Jan; 9(1):18-22. PubMed ID: 17325740
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Gemcitabine in advanced bladder cancer].
    Lehmann J; Retz M; Lippert C; Albers P; Stöckle M
    Urologe A; 2003 Jan; 42(1):63-77. PubMed ID: 12574885
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phase II study of gemcitabine and cisplatin in patients with advanced or metastatic bladder cancer: long-term follow-up of a 3-week regimen.
    Adamo V; Magno C; Spitaleri G; Garipoli C; Maisano C; Alafaci E; Adamo B; Rossello R; Scandurra G; Scimone A
    Oncology; 2005; 69(5):391-8. PubMed ID: 16319510
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy.
    Türkölmez K; Bedük Y; Baltaci S; Göğüş C; Göğüş O
    Eur Urol; 2003 Dec; 44(6):682-6. PubMed ID: 14644120
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.
    Loehrer PJ; Einhorn LH; Elson PJ; Crawford ED; Kuebler P; Tannock I; Raghavan D; Stuart-Harris R; Sarosdy MF; Lowe BA
    J Clin Oncol; 1992 Jul; 10(7):1066-73. PubMed ID: 1607913
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: results of a randomized phase 2 trial.
    Dogliotti L; Cartenì G; Siena S; Bertetto O; Martoni A; Bono A; Amadori D; Onat H; Marini L
    Eur Urol; 2007 Jul; 52(1):134-41. PubMed ID: 17207911
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Gemcitabine/cisplatin vs. MVAC. 5 year survival outcome of the phase III study of chemotherapy of advanced urothelial carcinoma in Germany].
    Lehmann J; Retz M; Steiner G; Albers P; Jaeger E; Knuth A; Lippert C; Koser M; Stockamp K; Otto C; Melchior H; Fassmann C; Potratz C; Loch T; Derigs HG; Becker T; Kälble T; Piechota HJ; Hertle L; Weinknecht S; Weissbach L; Al-Mwalad M; Hamza A; Henss H; Brkovic D; Pomer S; Roloff J; Walz P; Muschter R; Tunn U; Winter E; Bub P; Kaldenbach U; Roth S; Brauers A; Jakse G; Richter AE; Wirth M; Hartlapp J; Van Ahlen H; Stöckle M
    Urologe A; 2003 Aug; 42(8):1074-86. PubMed ID: 14513232
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Successful treatment of metastatic urothelial carcinoma arising in a transplanted renal allograft with paclitaxel, cisplatin, and gemcitabine combination therapy: a case report.
    Kojima Y; Takahi Y; Ichimaru N; Okumi M; Takahara S; Nonomura N
    BMC Res Notes; 2015 Feb; 8():25. PubMed ID: 25648269
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Possible alternative treatment for advanced transitional cell carcinoma of the urothelium (N+ and/or M+) in 1988.
    Perrin P; Mouriquand P; Monsallier M; Devonec M
    Prog Clin Biol Res; 1989; 303():617-9. PubMed ID: 2780666
    [No Abstract]   [Full Text] [Related]  

  • 74. The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy.
    Bamias A; Efstathiou E; Moulopoulos LA; Gika D; Hamilos G; Zorzou MP; Kakoyiannis C; Kastritis E; Bozas G; Papadimitriou C; Dimopoulos MA
    Ann Oncol; 2005 Feb; 16(2):307-13. PubMed ID: 15668289
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial.
    Pectasides D; Visvikis A; Aspropotamitis A; Halikia A; Karvounis N; Dimitriadis M; Athanassiou A
    Eur J Cancer; 2000 Jan; 36(1):74-9. PubMed ID: 10741298
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [First line therapy for local advanced or metastatic urothelial cell carcinoma: randomized phase II study to investigate the combination of vinflunine with gemcitabine and vinflunine with carboplatin in patients unfit for cisplatin therapy with advanced or metastatic urothelial cell carcinoma (JASINT-1 - AB 38/11) of AUO].
    Rexer H
    Urologe A; 2011 Aug; 50(8):974-6. PubMed ID: 21779884
    [No Abstract]   [Full Text] [Related]  

  • 78. Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder.
    Miller RJ; Bahnson RR; Banner B; Ernstoff MS; O'Donnell WF
    Cancer; 1990 Jan; 65(2):207-10. PubMed ID: 2295043
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987.
    Bellmunt J; von der Maase H; Mead GM; Skoneczna I; De Santis M; Daugaard G; Boehle A; Chevreau C; Paz-Ares L; Laufman LR; Winquist E; Raghavan D; Marreaud S; Collette S; Sylvester R; de Wit R
    J Clin Oncol; 2012 Apr; 30(10):1107-13. PubMed ID: 22370319
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Systemic therapy for unresectable and metastatic transitional cell carcinoma of the urothelium: first-line and beyond.
    Cheng T
    Curr Opin Support Palliat Care; 2008 Sep; 2(3):153-60. PubMed ID: 18685414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.